Covalon Technologies (OTCMKTS:CVALF) Trading 4.7% Higher

Covalon Technologies Ltd. (OTCMKTS:CVALF) traded up 4.7% during mid-day trading on Thursday . The company traded as high as $0.89 and last traded at $0.89. 400 shares were traded during mid-day trading, a decline of 93% from the average session volume of 5,577 shares. The stock had previously closed at $0.85.

Covalon Technologies Stock Performance

The company has a market capitalization of $22.24 million, a P/E ratio of -5.91 and a beta of -0.56. The business’s fifty day simple moving average is $0.87 and its 200-day simple moving average is $0.91.

Covalon Technologies (OTCMKTS:CVALF) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $3.43 million during the quarter. Covalon Technologies had a negative net margin of 19.70% and a negative return on equity of 23.88%.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.